凤凰网科技讯 北京时间10月11日，据路透社报道，美国得州马歇尔的联邦陪审团周五裁定，三星电子 因侵犯与4G、5G和WiFi通信标准相关的专利，需向专利所有者Collision Communications支付近4.455亿 美元(约合31.7亿元人民币)的赔偿金。 陪审团表示，三星的笔记本电脑、Galaxy智能手机以及其他支持无线功能的设备侵犯了Collision的四项 专利。该判决是近年来三星在同一马歇尔法院遭遇的多起赔偿金达九位数的专利侵权判决之一。 2023年，总部位于新罕布什尔州彼得伯勒的Collision起诉三星，指控其侵犯了与改进无线网络效率相关 的专利。Collision在诉讼中表示，这些专利源自国防承包商BAE系统公司开展的研究，但BAE并未参与 此案。 三星当时否认了相关指控，并辩称这些专利无效。 截至发稿，三星、Collision的发言人和律师均未立即回应置评请求。(作者/箫雨) ...

记者丨 叶映橙 见习记者林健民 李益文 编辑丨谢珍 宇树科技专利纠纷一案迎来阶段性句号。 9月30日，21财经·南财快讯记者从宇树科技内部工作人员处获悉，针对此前宇树科技被杭州露 韦美日化有限公司（下称"露韦美"）诉侵害发明专利权一案，浙江省杭州市中级人民法院已于 26日作出判决。根据民事判决书， 原告露韦美败诉，法院已驳回原告全部诉讼请求，宇树科 技不构成侵权。 （图：判决书） 今年8月，天眼查显示，露韦美与宇树科技相关侵害发明专利权纠纷的诉讼公开。相关案件于 2025年8月26日在杭州市中级人民法院开庭审理。 因是IPO前遭遇专利诉讼，故业内人士将该案视为对宇树科技IPO的一次"狙击" ，引发市场广 泛关注。 随后，露韦美实控人周建军在接受采访时称，不知道宇树科技正在准备上市，且他认为上市辅 导和股改都不属于上市之前，对外界的有关猜测不发表评论。 据悉，露韦美的诉讼请求是基于其2016年申请的一项名为"一种电子狗"的发明专利。天眼查知 识产权信息显示，露韦美已申请"一种电子狗"和"一种会议同声智能系统"专利，其中"一种电 子狗"专利已获授权。 不过，法院审理认定，露韦美未提供产品实物作为比对依据，且根据露 ...

宇树科技专利纠纷一案迎来阶段性句号。 9月30日，21财经·南财快讯记者从宇树科技内部工作人员处获悉，针对此前宇树科技被杭州露韦美日化有限公司（下称"露韦 美"）诉侵害发明专利权一案，浙江省杭州市中级人民法院已于26日作出判决。根据民事判决书，原告露韦美败诉，法院已驳回 原告全部诉讼请求，宇树科技不构成侵权。 （图：判决书） 今年8月，天眼查显示，露韦美与宇树科技相关侵害发明专利权纠纷的诉讼公开。相关案件于2025年8月26日在杭州市中级人民 法院开庭审理。 因是IPO前遭遇专利诉讼，故业内人士将该案视为对宇树科技IPO的一次"狙击"，引发市场广泛关注。 随后，露韦美实控人周建军在接受采访时称，不知道宇树科技正在准备上市，且他认为上市辅导和股改都不属于上市之前，对 外界的有关猜测不发表评论。 据悉，露韦美的诉讼请求是基于其2016年申请的一项名为"一种电子狗"的发明专利。天眼查知识产权信息显示，露韦美已申 请"一种电子狗"和"一种会议同声智能系统"专利，其中"一种电子狗"专利已获授权。 不过，法院审理认定，露韦美未提供产品实物作为比对依据，且根据露韦美的现有证据，被诉产品的技术方案并不具备涉案专 利主权利要求 ...

9月30日，据第一财经报道，针对此前宇树科技被杭州露韦美日化有限公司诉侵害发明专利权一案，浙江省杭州市中级人民法院已于26日作出判决。根据 民事判决书，原告杭州露韦美日化有限公司败诉，法院已驳回原告全部诉讼请求，宇树科技不构成侵权。 回溯该起专利权纠纷案，涉及的专利是名为"一种电子狗"（专利号ZL201610396363 .0）的发明专利。"一种电子狗"专利公开时间为2017年2月8日，在2018 年获得授权，发明人为周建军。而宇树科技第一款四足机器人莱卡狗（Laikago），发布于2017年10月，从时间线来看，晚于露韦美专利公开时间，但露 韦美目前尚未有"一种电子狗"公开的销售情况。 经查询，该专利原始权利人为浙江建林电子电气股份有限公司（周建军名下的另一家企业） ，今年1月16日转让至杭州连好科技贸易有限公司，又于6月 25日转让至该案原告，虽然历经两手转让，但是原始权利人和最终权利人的法人均为周建军，实际上属于周建军企业之间的相互转让。 宇树科技成立于2016年，创始人王兴兴带领公司从一人创业发展至千人团队，年营收已突破10亿元。 国家企业信用信息公示系统显示，露韦美成立于2005年6月，注册资本55 ...

判决书截图。 9月30日，记者获悉，针对此前宇树科技被杭州露韦美日化有限公司诉侵害发明专利权一案，浙江省杭州市中级人民法院已于26日作出判决。 根据该案一审判决书，原告杭州露韦美日化有限公司败诉，法院已驳回原告全部诉讼请求，宇树科技不构成侵权。 此前，原告法定代表人周建军告诉记者，其主张自己发明的"电子狗"专利申请时间早于宇树科技的注册时间，认为宇树科技的四足机器狗产品对其"电子 狗"的发明专利产生侵权，并否认此次诉讼纠纷是针对宇树科技上市进程的"专利狙击"。 原告所持专利"一种电子狗"专利此前在周建军控股的浙江建林电子电气股份有限公司名下。该公司成立于2002年6月18日，主要从事电子元器件、电气产品 的批发零售及智能设备生产，公司持有有关"元宇宙的智能商城服务交易平台""基于区块链的金融交易溯源方法"等122项专利，2014年该公司在浙江股权交 易中心挂牌。 法院指出，露韦美公司未提供产品实物作为比对依据，且根据露韦美公司的现有证据，被诉产品的技术方案并不具备涉案专利主权利要求及相关从权利要求 所限定的相关必要技术特征，认定其主张被诉产品构成侵权的理由不能成立。 （九派新闻） 除宇树科技外，周建军通过浙江 ...

2025.09. 27 本文字数：2198，阅读时长大约4分钟 作者 | 第一财经 陆如意 继2023年"借壳上市"失败后，海辰储能的第二次资本化尝试再次受阻。 今年3月25日，海辰储能向港交所递交招股申请书，期间的联席保荐人为华泰国际、中信证券、农银国 际、中银国际。截至9月25日，其港股招股书失效。 据港交所规定，企业递交的招股书有效期为6个月，若未在6个月期限内完成上市聆讯，招股书将自动 失效。后续拟上市企业若希望继续推进上市，可选择更新相关财务数据和业务进展信息，并重新提交申 请。 因此，招股书失效属于港交所的正常程序性规则， 不应被"粗暴"地解读为IPO"折戟"。 但是，在没有 完成证监会备案和港交所聆讯的情况下失效，说明该公司"尚未准备好"或上市进程确实存在一些"关 卡"。 三次遭"宁王"专利诉讼 除了专利端的"高度重叠"，两者在核心高管及技术团队上也有"重叠"。海辰储能可以说是"脱胎于"宁 德时代，海辰储能创始人吴祖钰及多名高管此前有过宁德时代任职履历。 "跑马圈地"下的财务压力 在上市审批过程中，联交所会就拟上市公司的业务模式、关联交易、独立性、法律合规、财务数据等进 行多轮问询。 而在港股I ...

Core Points - Cerence has filed a patent infringement lawsuit against Apple, focusing on "Hey, Siri" and virtual keyboard technology [1] - The lawsuit was submitted in the Western District of Texas, revealing that Cerence had previously engaged in discussions with Apple regarding potential acquisition or licensing of multiple patents since 2021 [3] - Cerence claims that despite providing key documents and engaging in discussions, no resolution was reached regarding the mobile text input patent portfolio [3] - The company is seeking a court ruling to declare Apple in violation of these patents and is requesting damages for the infringement, along with ongoing licensing fees [3]

Core Viewpoint - The core issue revolves around Huawei's lawsuit against Transsion for allegedly using Huawei's patented video compression technology without permission, specifically a technology that enhances video quality post-compression, known as AI image restoration master [1] Group 1 - Huawei applied for the European patent in 2011, which is now at the center of the legal dispute [1] - The technology in question is designed to prevent video quality degradation after compression, indicating its significance in video processing [1] - The lawsuit suggests that Transsion may have utilized Huawei's proprietary technology in its video processing capabilities, raising concerns about intellectual property theft [1]

Core Viewpoint - CyboEnergy has filed a patent infringement lawsuit against Deye ESS Technology USA and Ningbo Deye Inverter Technology Co Ltd, alleging that Deye's microinverters infringe on its patented technologies related to solar inverters [1][18]. Group 1: Patent Details - The lawsuit involves two U.S. patents: US9331488B2, which covers smart and scalable power inverters, and US8786133B2, which pertains to the enclosure and message system of these inverters [1][4]. - Patent US9331488B2 was filed on June 29, 2012, and granted on May 3, 2016, with an expiration date of December 17, 2034. It focuses on a hardware architecture that integrates multiple DC input channels and centralized control [2][4]. - Patent US8786133B2 was filed on July 15, 2010, and granted on July 22, 2014, expiring on June 7, 2032. It addresses issues related to traditional centralized DC-AC inverters, offering a more efficient and reliable solution for distributed energy integration [4][20]. Group 2: Products Involved - The products in question include Deye's SUN series microinverters: SUN600G3, SUN800G3, SUN1000G3, SUN1300G3, SUN1600G3, and SUN2000G3, which range in power from 300W to 2000W and support various communication methods [1][9]. - Deye's microinverters are designed to optimize power generation at the module level, providing features such as remote monitoring and quick shutdown capabilities [9][11]. Group 3: Legal Proceedings - CyboEnergy claims that Deye knowingly sold and provided products that infringe on its patents, actively promoting their use through various marketing materials [18][19]. - The lawsuit seeks several remedies, including a determination of infringement, compensation for damages, and a permanent injunction against future infringement [19][20]. - There are potential disputes regarding the specifics of the technology used in Deye's products and whether they indeed infringe on CyboEnergy's patents, as the initial complaint lacks detailed technical analysis [20][21].

Core Viewpoint - The company, Times Angel, reported a significant increase in revenue and net profit for the first half of 2025, but is facing a patent infringement lawsuit from Align Technology, the parent company of Invisalign, which could impact its international expansion plans [1][3][4]. Financial Performance - Times Angel achieved revenue of $161 million, a 33.1% increase year-over-year, and a net profit of $14 million, reflecting a 583.6% increase compared to the same period last year [1]. - This marks the first positive net profit growth in the mid-year results for Times Angel in three years [1]. Business Segmentation - The invisible orthodontic solutions contributed approximately 53.4% of the total revenue, generating $86 million, with a total case number growth of 47.7% to about 225,800 cases [2]. - In the Chinese market, the case number reached approximately 108,600, a 14% year-over-year increase, while the international market saw a case number growth of 103.5% to about 117,200 cases [2]. - The company reported a slight revenue increase of 0.7% in the mainland China market, totaling $89.7 million, with a segment operating profit of $17.19 million, a 52.1% increase [2]. Challenges and Legal Issues - Times Angel is currently facing a patent infringement lawsuit initiated by Align Technology, which claims that Times Angel's products and related software infringe on multiple patents related to orthodontic innovations [3]. - The lawsuit has been filed in key jurisdictions including the United States, Europe, and China, where Align has heavily invested in innovation and manufacturing [3]. - Times Angel has publicly denied the infringement claims, asserting that the competitor's allegations are baseless [4]. Strategic Adjustments - To counteract intense competition, Times Angel has implemented strategic price adjustments, which have successfully attracted more end customers, particularly in lower-tier markets and early treatment segments [2]. - The company plans to establish a manufacturing facility in the United States by 2025, indicating its ambition to expand its global footprint despite the ongoing legal challenges [4].